Middle East and Africa Pharmaceutical Isolator Market Growth and Forecast by 2028

The MEA pharmaceutical isolator market is expected to grow from US$ 258.00 million in 2021 to US$ 426.54 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2021 to 2028.

The UAE, Saudi Arabia, and South Africa are major economies in MEA. Burgeoning pharmaceutical and biotechnological industries is expected to surge the market growth. The expenditure on pharmaceutical research in MEA countries are growing. In addition, various countries in the region can adopt advanced technologies such as aseptic isolators. They are also engaged in the development of cost-effective and high-performance systems to become advanced drug developers in the region. Emerging countries would offer lucrative growth opportunities for the players in the market owing to their diversified healthcare markets, low labor, and raw material costs, rise in life science research activities, government support, the rapid growth of CROs and the pharmaceutical industries, and technological integration and advancements. The governments of emerging countries have also spent significantly on encouraging research in the pharmaceutical industry. Moreover, the increasing interest of pharmaceutical companies in drug discovery outsourcing due to the ever-increasing demand for better drugs, limited drug pipelines, and rise in R&D costs is further fueling the demand for aseptic isolators in emerging markets.  Furthermore, several MEA countries are emerging as attractive outsourcing locations for biopharmaceutical manufacturers across the region. Low manufacturing and operating costs in countries are key factors driving the pharmaceutical isolator growth in region. Moreover, recent developments in the biopharmaceutical industry indicate significant potential for the market. All the aforementioned factors would offer lucrative opportunities for the MEA pharmaceutical isolator market in emerging economies during the forecast period.

In case of COVID-19, MEA is highly affected especially South Africa. The coronavirus pandemic has become the largest challenge to this region, as they are low-cost regions. For instance, due to the high uncertainty of the spread of COVID-19, the impact on Africa is expected to be severe, given the continent’s exposure to China. These regions are widely dependent on the import of pharmaceutical and biopharmaceutical equipment. The lockdown situation in many countries has resulted in no trade in foreign countries. Thus, the countries in the MEA have started producing API in their domestic market. However, the cost of production was a challenge for several countries. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for aseptic processing of pharmaceutical products. This scenario is expected to offer several growth opportunities for pharmaceutical isolator market. In South Africa, adoption of aseptic processing during pandemic has significantly witnessed high growth, which is expected to increase the demand for pharmaceutical isolator market. For instance, Esco Technologies Pty Ltd has offered Esco Class II Biological Safety Cabinets to various laboratories and testing facilities in South Africa. Biosafety cabinets pose great importance in handling biohazards in COVID-19 testing facilities. All these factors will positively impact the pharmaceutical isolator market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA pharmaceutical isolator market. The MEA pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.

MEA Pharmaceutical Isolator Market Segmentation        

MEA Pharmaceutical Isolator Market – By Type

• Open Isolators
• Closed Isolators

MEA Pharmaceutical Isolator Market – By Pressure

• Positive Pressure
• Negative Pressure

MEA Pharmaceutical Isolator Market – By Configuration

• Floor Standing
• Modular
• Compact
• Mobile

MEA Pharmaceutical Isolator Market – By Application

• Aseptic
• Sampling & Weighing
• Fluid Dispensing
• Containment    
• Others

MEA Pharmaceutical Isolator Market – By End User

• Pharmaceutical and Biotechnology Companies
• Hospitals
• Research and Academic Laboratories
• Other

MEA Pharmaceutical Isolator Market, by Country

• Saudi Arabia 
• UAE 
• South Africa
• Rest of MEA

MEA Pharmaceutical Isolator Market -Companies Mentioned

• Azbil Telstar
• Bioquell (Ecolab Solution)
• Comecer
• Fedegari Autoclavi S.p.A.
• Getinge AB 
• Hosokawa Micron Group
• Nuaire Inc.

Middle East and Africa Pharmaceutical Isolator Report Scope